… Targeting immune evasion via immune checkpoint pathways has changed the treatment …
, eight immune checkpoint inhibitors (ICIs) centered on PD-1 pathway blockade are approved …

… benefit from immune checkpoint blockade. Basic science approaches and clinical experience
… to broaden the clinical impact of immune checkpoint blockade by overcoming resistance to …

… immune checkpoints are currently under clinical development. In this review, we summarize
the evidence supporting the implementation of checkpoint inhibition … with checkpoint inhibitor…

… Recent studies suggest that a combination of immune checkpoint inhibitors and IFNa-2b
can enhance clinical efficacy in metastatic melanoma [105,106]. Interferon-gamma (IFNγ), a …

… immune checkpoint inhibition and its beneficial role in cancer immunotherapy, the broad role
of checkpoint molecules in immunity … clinical applications in the field of immune checkpoint …

… biomarkers for immune checkpoint inhibitors in NSCLC patients with BM. In addition, clinical
data … Here, we review the theoretical basis and clinical data for the application of ICIs in the …

… stories have been achieved with immune checkpoint inhibitors (ICIs), but … clinical arena.
Oncolytic viruses such as talimogene laherparepvec or the autologous cellular immunological …

… L1 Immune-checkpoint inhibitors and its future prospects. Although PD-1/PD-L1 immune
checkpoint inhibitors … for the application of PD-1/PD-L1 Immune-checkpoint inhibitors in treating …

… has been made in the clinical application of cancer immunotherapies. Most notable is the
emergence of immune checkpoint inhibitors. Large-scale clinical trials have shown their …

… checkpoints in these … to the use of such inhibitors when T cells themselves are the target
cells, and consider future approaches to refine clinical trials with immune checkpoint inhibitors in …